Spruce Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SPRB and buy or sell other stocks, ETFs, and their options commission-free!

About SPRB

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. 

CEO
Javier Szwarcberg
CEOJavier Szwarcberg
Employees
21
Employees21
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2014
Founded2014
Employees
21
Employees21

SPRB Key Statistics

Market cap
3.15M
Market cap3.15M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
—
Dividend yield—
Average volume
434.49K
Average volume434.49K
High today
$0.0831
High today$0.0831
Low today
$0.07
Low today$0.07
Open price
$0.0763
Open price$0.0763
Volume
77.05K
Volume77.05K
52 Week high
$0.6723
52 Week high$0.6723
52 Week low
$0.057
52 Week low$0.057

People also own

Based on the portfolios of people who own SPRB. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
Mullen Automotive
Workhorse
Tilray Brands
Bionano Genomics
SNDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.